Sputnik V COVID-19 Vaccine Causing A Stir In The EU
No Special Inquiry Into Clinical Trials, Says EMA
The team behind Sputnik V has attacked what it calls “fake news and provocations” in the EU as political arguments over the vaccine claim another ministerial scalp.
You may also be interested in...
While the EU attempts to accelerate the pace of its unified approach to vaccine roll-out, some eastern European countries are taking their own decisions.
Drug approvals, clinical trials, pharmacovigilance and the use of unauthorized drugs are among areas targeted by draft legislation on a new therapeutic products scheme.
With efforts continuing to maximize access to medical countermeasures against the pandemic threat, a webinar organized by NGOs looked at progress with and the shortcomings of the WHO’s C-TAP initiative, recent moves by the WHO on access provisions in funding agreements, and plans for a global C-TAP database.